Latest filing published 17 Jun 2026 for Pharmala Biotech Holdings Inc., €9,254. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jodi Lynn Heimpel Butts has filed trades across 2 companies (mainly through SEDI), most often in Canada Goose Holdings Inc. and Pharmala Biotech Holdings Inc. In total, 16 filings cover trades dated from 28 May 2026 to 15 June 2026.
No open-market purchase appears, only 4 sales worth €19k. Outside the open market, there are 1 share grant and 11 option exercises.
The newest entry dates from 17 June 2026: an option exercise of €9,254, in Pharmala Biotech Holdings Inc. The median gap between a trade and its publication by SEDI is 4 days. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations